Landscape analysis of commercially available and pipeline in vitro diagnostics for fungal priority pathogens
The World Health Organization (WHO) has conducted a comprehensive analysis of commercially available diagnostic products and pipeline diagnostic products for invasive fungal diseases (IFDs) caused by WHO Fungal Priority Pathogens. The report focuses on in vitro diagnostics (IVDs) that can help limit and identify antimicrobial resistance (AMR). IFDs pose a growing global health threat, with over 6.5 million infections and 3.8 million deaths annually. The WHO has established its first Fungal Priority Pathogens list in 2022 to prioritize research and development in this area.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!
